Faculty member receives grant from Novo Nordisk to study potential cause of obesity

James Johnson, associate professor in the Dept. of Cellular and Physiological Sciences, has won a $625,000 grant from Novo Nordisk to pursue research that could upend conventional notions about the interplay between insulin, obesity and diabetes.

Johnson and his team will use the award to continue his experiments on the effects of varying levels of insulin and different types of insulin, testing the idea that high levels of circulating insulin might actually be a cause of obesity, rather than an indirect effect.

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 88 years of innovation and leadership in diabetes care.

For more information, visit this page.